Roundhill Russell 2000 0DTE Covered Call Strat ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $25.96 (market cap $159.33M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 158.6× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Roundhill Russell 2000 0DTE Covered Call Strat ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| RDTE | RPRX | |
|---|---|---|
Market Cap | $159.33M | $25.27B |
Volume | 248,058 | 3,671,183 |
Sector | Income / Options Overlay | Health |
52-Week High | $33.66 | $63.96 |
52-Week Low | $25.96 | $35.44 |
Typical Hold Time | 53 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →